פוסטר 1006 ישראל - עברית - Ministry of Health

פוסטר 1006

kamada ltd, israel - beclometasone dipropionate anhydrous; formoterol fumarate dihydrate - תמיסה לשאיפה - formoterol fumarate dihydrate 6 mcg/dose; beclometasone dipropionate anhydrous 100 mcg/dose - formoterol and beclometasone - beclometasone - foster is indicated in the regular treatment of asthma where use of a combination product (inhaled corticosteroid and long-acting beta2-agonist) is appropriate:- patients not adequately controlled with inhaled corticosteroids and 'as needed' inhaled short-acting beta2-agonist or- patients already adequately controlled on both inhaled corticosteroids and long-acting beta2-agonists.

אנג'מיצין ספריי וטרינרי ישראל - עברית - Ministry of Health

אנג'מיצין ספריי וטרינרי

intervet ( israel) ltd - oxytetracycline hydrochloride - oxytetracycline hydrochloride 25 mg/ml

צפוניציד טבע ישראל - עברית - Ministry of Health

צפוניציד טבע

salomon,levin & elstein ltd - cefonicide as sodium - אבקה להכנת תמיסה לזריקה - cefonicide as sodium 1000 mg/vial - cefonicide - cefonicide - treatment of serious bacterial infections caused by microorganisms susceptible to cefonicid. studies on specimens obtained prior to therapy should be used to determine the susceptibility or the causative organisms to cefonicid.therapy with cefonicid may be initiated pending results of the studies however.treatment should be adjusted according to study findings. cefonicid-teva is indicated in the treatment of the infections of the lower respiratory tract urinary tract skin and skin structure bone and joints. in the treatment of the above-mentioned infections the product is particularly used in weak and/or immuno-depressed patients. surgical prophylaxis: the administration of a single 1 g. dose of cefonicid-teva before surgery may reduce the incidence of post-operative infections caused by susceptible microorganisms in patients undergoing surgical procedures classified as contaminated or potentially contaminated or in patients in whom infection at the operative site would present a serious risk providing protec

דופמין הידרוכלוריד ס.א.ל.פ 40 מג1 מל ישראל - עברית - Ministry of Health

דופמין הידרוכלוריד ס.א.ל.פ 40 מג1 מל

raz pharmaceutics ltd, israel - dopamine hydrochloride - תרכיז להכנת תמיסה לאינפוזיה - dopamine hydrochloride 40 mg / 1 ml - dopamine

Eyeronic ישראל - עברית - Ministry of Health

eyeronic

medicure technologies ltd - כלל האוכלוסיה - תמיסת עיניים המכילה חומצה היאלורונית קמומיל ודרדר כחול להקלה במצבי יובש בעיניים

גליצרז מבוגרים ישראל - עברית - Ministry of Health

גליצרז מבוגרים

raz pharmaceutics ltd, israel - glycerol - פתילות - glycerol 2250 mg - glycerol

קורוסן 75 מג ישראל - עברית - Ministry of Health

קורוסן 75 מג

raz pharmaceutics ltd, israel - dipyridamole - טבליה - dipyridamole 75 mg - dipyridamole

טיאסר 50 מ"ג ישראל - עברית - Ministry of Health

טיאסר 50 מ"ג

bioavenir ltd - losartan as potassium 50 mg - tablets - losartan - hypertension: losartan is indicated for the treatment of heart failure ( nyha ii and iii) usually in addition to diuretics and/or digitalis if use of an ace inhibitor is not appropriate. switching patients with heart failure who are stable on an ace inhibitor to tiasar is not recommended. renal protection in type - 2 diabetic patients with proteinuria: losartan is indicated to delay the progression of renal disease as measured by a reduction in the combined incidence of doubling of serum creatinine end stage renal disease ( need for dialysis or renal transplantation) or death and to reduce proteinuria. reduction in the risk of cardiovascular morbidity and mortality in hypertensive patients with left ventricular hypertrphy. losartan is indicated to reduce the risk of cardiovascular morbidity and mortality as measured by the combined incidence of cardiovascular death stroke and myocardial infarction in hypertensive patients with left ventricular hypertrphy. the benefit of tiasar on the primary deposite end poin